VivoSim Labs
VIVS
110 hedge funds and large institutions have $55.6M invested in VivoSim Labs in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 9 closing their positions.
67% more capital invested
Capital invested by funds: $33.3M → $55.6M (+$22.3M)
67% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 9
21% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 24
5% more funds holding
Funds holding: 105 → 110 (+5)
0.02% more ownership
Funds ownership: 0.12% → 0.14% (+0.02%)
12% less call options, than puts
Call options by funds: $94K | Put options by funds: $107K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$4.96M |
| 2 |
BlackRock
New York
|
+$1.23M |
| 3 |
Renaissance Technologies
New York
|
+$1.1M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$311K |
| 5 |
D.E. Shaw & Co
New York
|
+$256K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$225K |
| 2 |
Goldman Sachs
New York
|
-$201K |
| 3 |
EWM
Edge Wealth Management
New York
|
-$83K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$55.6K |
| 5 |
Barclays
London,
United Kingdom
|
-$30.6K |
VIVS Hedge Fund Activity: Q2 2018 in Review
110 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q2 2018, worth a combined $55.6M — up 67% from $33.3M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new VIVS positions and 9 closed out — a net gain of 6 holders — while 29 added to existing stakes and 24 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $4.96M. The largest seller was Bridgeway Capital Management, cutting an estimated $225K.
- 110 institutional investors held VivoSim Labs (VIVS) as of Q2 2018, up from 105 in Q1 2018.
- Funds reported $55.6M of VivoSim Labs stock for Q2 2018, up 67% quarter-over-quarter.
- 15 funds opened new VivoSim Labs positions in Q2 2018 and 9 closed out, a net change of +6 holders.
- The largest VivoSim Labs buyer in Q2 2018 was ARK Investment Management, an estimated $4.96M added.
- The largest VivoSim Labs seller in Q2 2018 was Bridgeway Capital Management, an estimated $225K sold.
Based on aggregated 13F filings for Q2 2018.